DE2350679A1 - Medikament zum behandeln von und vorbeugen gegen heliencephalitis, thermoplegie und streitsucht bei haustieren und gefluegel - Google Patents
Medikament zum behandeln von und vorbeugen gegen heliencephalitis, thermoplegie und streitsucht bei haustieren und gefluegelInfo
- Publication number
- DE2350679A1 DE2350679A1 DE19732350679 DE2350679A DE2350679A1 DE 2350679 A1 DE2350679 A1 DE 2350679A1 DE 19732350679 DE19732350679 DE 19732350679 DE 2350679 A DE2350679 A DE 2350679A DE 2350679 A1 DE2350679 A1 DE 2350679A1
- Authority
- DE
- Germany
- Prior art keywords
- heliencephalitis
- poultry
- animals
- acid
- treat
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 244000144977 poultry Species 0.000 title claims description 12
- 241001465754 Metazoa Species 0.000 claims description 24
- 239000002253 acid Substances 0.000 claims description 10
- 150000001875 compounds Chemical class 0.000 claims description 10
- 239000003814 drug Substances 0.000 claims description 7
- 150000003839 salts Chemical class 0.000 claims description 5
- GYDJEQRTZSCIOI-UHFFFAOYSA-N Tranexamic acid Chemical compound NCC1CCC(C(O)=O)CC1 GYDJEQRTZSCIOI-UHFFFAOYSA-N 0.000 claims description 4
- 150000007860 aryl ester derivatives Chemical class 0.000 claims description 4
- 229940079593 drug Drugs 0.000 claims description 4
- 150000007513 acids Chemical class 0.000 claims description 3
- 125000005907 alkyl ester group Chemical group 0.000 claims description 2
- 206010019345 Heat stroke Diseases 0.000 description 13
- 241000282887 Suidae Species 0.000 description 8
- 229960002684 aminocaproic acid Drugs 0.000 description 5
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 5
- QCTBMLYLENLHLA-UHFFFAOYSA-N aminomethylbenzoic acid Chemical compound NCC1=CC=C(C(O)=O)C=C1 QCTBMLYLENLHLA-UHFFFAOYSA-N 0.000 description 4
- 229960003375 aminomethylbenzoic acid Drugs 0.000 description 4
- 201000010099 disease Diseases 0.000 description 4
- 230000035876 healing Effects 0.000 description 4
- SLXKOJJOQWFEFD-UHFFFAOYSA-N 6-aminohexanoic acid Chemical compound NCCCCCC(O)=O SLXKOJJOQWFEFD-UHFFFAOYSA-N 0.000 description 3
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 3
- 230000037396 body weight Effects 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 2
- 241000282898 Sus scrofa Species 0.000 description 2
- 125000000217 alkyl group Chemical group 0.000 description 2
- ISAOCJYIOMOJEB-UHFFFAOYSA-N benzoin Chemical compound C=1C=CC=CC=1C(O)C(=O)C1=CC=CC=C1 ISAOCJYIOMOJEB-UHFFFAOYSA-N 0.000 description 2
- 230000036760 body temperature Effects 0.000 description 2
- 239000003795 chemical substances by application Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 230000032258 transport Effects 0.000 description 2
- DSSYKIVIOFKYAU-XCBNKYQSSA-N (R)-camphor Chemical compound C1C[C@@]2(C)C(=O)C[C@@H]1C2(C)C DSSYKIVIOFKYAU-XCBNKYQSSA-N 0.000 description 1
- 208000019901 Anxiety disease Diseases 0.000 description 1
- 208000014644 Brain disease Diseases 0.000 description 1
- 241000723346 Cinnamomum camphora Species 0.000 description 1
- 206010010904 Convulsion Diseases 0.000 description 1
- 206010012218 Delirium Diseases 0.000 description 1
- 206010013033 Diplegia Diseases 0.000 description 1
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 1
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- 241000220317 Rosa Species 0.000 description 1
- 244000028419 Styrax benzoin Species 0.000 description 1
- 235000000126 Styrax benzoin Nutrition 0.000 description 1
- 235000008411 Sumatra benzointree Nutrition 0.000 description 1
- 239000004480 active ingredient Substances 0.000 description 1
- 230000001154 acute effect Effects 0.000 description 1
- 238000010171 animal model Methods 0.000 description 1
- 239000007864 aqueous solution Substances 0.000 description 1
- 229960002130 benzoin Drugs 0.000 description 1
- 159000000007 calcium salts Chemical class 0.000 description 1
- 229960000846 camphor Drugs 0.000 description 1
- 229930008380 camphor Natural products 0.000 description 1
- 210000000748 cardiovascular system Anatomy 0.000 description 1
- 230000015556 catabolic process Effects 0.000 description 1
- 210000003710 cerebral cortex Anatomy 0.000 description 1
- 230000002490 cerebral effect Effects 0.000 description 1
- 208000002173 dizziness Diseases 0.000 description 1
- 239000003937 drug carrier Substances 0.000 description 1
- -1 gaffeine Chemical compound 0.000 description 1
- 235000019382 gum benzoic Nutrition 0.000 description 1
- 230000012447 hatching Effects 0.000 description 1
- 238000002347 injection Methods 0.000 description 1
- 239000007924 injection Substances 0.000 description 1
- 210000001767 medulla oblongata Anatomy 0.000 description 1
- 150000007522 mineralic acids Chemical class 0.000 description 1
- 210000005036 nerve Anatomy 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 230000000384 rearing effect Effects 0.000 description 1
- 238000011084 recovery Methods 0.000 description 1
- 239000011734 sodium Substances 0.000 description 1
- 229910052708 sodium Inorganic materials 0.000 description 1
- 238000010254 subcutaneous injection Methods 0.000 description 1
- 239000007929 subcutaneous injection Substances 0.000 description 1
- 238000002560 therapeutic procedure Methods 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
- C07C229/00—Compounds containing amino and carboxyl groups bound to the same carbon skeleton
- C07C229/38—Compounds containing amino and carboxyl groups bound to the same carbon skeleton having amino groups bound to acyclic carbon atoms and carboxyl groups bound to carbon atoms of six-membered aromatic rings of the same carbon skeleton
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23K—FODDER
- A23K20/00—Accessory food factors for animal feeding-stuffs
- A23K20/10—Organic substances
- A23K20/142—Amino acids; Derivatives thereof
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/185—Acids; Anhydrides, halides or salts thereof, e.g. sulfur acids, imidic, hydrazonic or hydroximic acids
- A61K31/19—Carboxylic acids, e.g. valproic acid
- A61K31/195—Carboxylic acids, e.g. valproic acid having an amino group
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/21—Esters, e.g. nitroglycerine, selenocyanates
- A61K31/215—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids
- A61K31/235—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group
- A61K31/24—Esters, e.g. nitroglycerine, selenocyanates of carboxylic acids having an aromatic ring attached to a carboxyl group having an amino or nitro group
- A61K31/245—Amino benzoic acid types, e.g. procaine, novocaine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/20—Hypnotics; Sedatives
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Veterinary Medicine (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Epidemiology (AREA)
- Organic Chemistry (AREA)
- Emergency Medicine (AREA)
- Engineering & Computer Science (AREA)
- Polymers & Plastics (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Animal Husbandry (AREA)
- Zoology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Food Science & Technology (AREA)
- Anesthesiology (AREA)
- Biomedical Technology (AREA)
- Neurology (AREA)
- Neurosurgery (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
- Fodder In General (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP10224672A JPS5310136B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1972-10-12 | 1972-10-12 |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DE2350679A1 true DE2350679A1 (de) | 1974-04-18 |
Family
ID=14322240
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DE19732350679 Pending DE2350679A1 (de) | 1972-10-12 | 1973-10-09 | Medikament zum behandeln von und vorbeugen gegen heliencephalitis, thermoplegie und streitsucht bei haustieren und gefluegel |
Country Status (9)
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5452974A (en) * | 1993-03-04 | 1995-09-26 | Air Industries Corporation | Deformable locking fastener system and method of use |
-
1972
- 1972-10-12 JP JP10224672A patent/JPS5310136B2/ja not_active Expired
-
1973
- 1973-10-08 ZA ZA737853A patent/ZA737853B/xx unknown
- 1973-10-09 DE DE19732350679 patent/DE2350679A1/de active Pending
- 1973-10-09 NL NL737313856A patent/NL149373B/xx not_active IP Right Cessation
- 1973-10-11 US US05/405,494 patent/US3956503A/en not_active Expired - Lifetime
- 1973-10-11 GB GB4763073A patent/GB1426778A/en not_active Expired
- 1973-10-11 ES ES419587A patent/ES419587A1/es not_active Expired
- 1973-10-11 AU AU61293/73A patent/AU497649B2/en not_active Expired
- 1973-10-12 AT AT870173A patent/AT327600B/de not_active IP Right Cessation
Cited By (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US5452974A (en) * | 1993-03-04 | 1995-09-26 | Air Industries Corporation | Deformable locking fastener system and method of use |
Also Published As
| Publication number | Publication date |
|---|---|
| AU497649B2 (en) | 1978-12-21 |
| JPS4961316A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1974-06-14 |
| NL7313856A (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1974-04-16 |
| US3956503A (en) | 1976-05-11 |
| JPS5310136B2 (GUID-C5D7CC26-194C-43D0-91A1-9AE8C70A9BFF.html) | 1978-04-11 |
| NL149373B (nl) | 1976-05-17 |
| GB1426778A (en) | 1976-03-03 |
| ZA737853B (en) | 1974-09-25 |
| ATA870173A (de) | 1975-04-15 |
| AT327600B (de) | 1976-02-10 |
| AU6129373A (en) | 1975-04-17 |
| ES419587A1 (es) | 1977-04-01 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DE69920201T2 (de) | Zusammensetzungen enthaltend glykolderivate, alkohole und vitamin d | |
| DE1793315B1 (de) | 2-Methylamino-2-(o-chlorphenyl)-cyclohexanon und seine pharmakologisch vertraeglichen Saeureadditionsverbindungen | |
| DE69003906T2 (de) | Triacetin enthaltende, langwirkende injizierbare Zusammensetzungen. | |
| EP0188810A2 (de) | Verwendung von Dipeptidderivaten für die Herstellung von Arzneimitteln zur Verhinderung oder Behandlung posttraumatischer Nervenschäden nach unfallbedingten Rückenmarks- und/oder Gehirntraumen | |
| DE69726143T2 (de) | Verwendung von pharmazeutische Zusammensetzungen enthaltend Thymol und/oder Carvacrol in der Behandlung von Histomoniasis | |
| DE3531545A1 (de) | Arzneimittel mit einem gehalt an calcium-antagonisten und deren verwendung | |
| DE2350721A1 (de) | Neues, in der ophthalmologie einsetzbares medikament | |
| DE2206570B2 (de) | Verwendung von ( + ) - Catechin | |
| DE2640322A1 (de) | Medizinische zubereitung mit einem gehalt an nebennierenrindenhormon und einem ein schilddruesenstimulierendes hormon freisetzenden hormon | |
| DE2350679A1 (de) | Medikament zum behandeln von und vorbeugen gegen heliencephalitis, thermoplegie und streitsucht bei haustieren und gefluegel | |
| DE2720288C2 (de) | Verwendung von Magnesiumsalzen zur Herstellung von Zubereitungen zur Behandlung von Nutztieren | |
| DE2528460A1 (de) | Verwendung von l-carboxamido-2- cyan-aziridin als immunstimulans | |
| DE3730957C2 (de) | Lösliches Thiamphenicol-Präparat | |
| DE60012183T2 (de) | Verwendung einer makrolid-verbindung zur herstellung eines medikaments zur behandlung von gehirnschäden aufgrund von ischämie oder blutungen | |
| DE69132145T2 (de) | Peritoneal wirksame medikamente | |
| DE2221281C3 (de) | Pharmazeutische Zubereitungen mit entzündungshemmender und analgetischer Wirkung | |
| DE2633891A1 (de) | Neues salz der alpha-methylbenzoyl- 5-thiophen-2-essigsaeure, verfahren zu dessen herstellung und pharmazeutische zusammensetzungen | |
| DE1617508C3 (de) | Antidepressive Mittel | |
| DE2801867A1 (de) | Antikoagulans-arzneimittel auf der basis von heparin | |
| DE2130346C3 (de) | Unterstützende Mittel bei malignen Geschwulsterkrankungen und viricide Mittel | |
| DE1767352C (de) | Subkutan zu verabreichendes Veterinär-Arzneimittel zur Verbesserung des Fleischansatzes | |
| DE3030314A1 (de) | Arzneimittel auf sulfonamidbasis | |
| DE69431320T2 (de) | Verwendung von menschlichem Interferon-d zur Herstellung eines Arzneimittels zur Behandlung von Atemwegserkrankungen in Katzen | |
| DE3400598A1 (de) | Verwendung von avilamycin zur bekaempfung von schweinedysenterie | |
| AT518982B1 (de) | Arzneimittel gegen männliche Sterilität |